Literature DB >> 10787335

Treatment of allergic asthma with monoclonal anti-IgE antibody.

S S Salvi, K S Babu.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10787335     DOI： 10.1056/NEJM200004273421715

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  4 in total

1.  Elicitation of allergic asthma by immunoglobulin free light chains.

Authors:  Aletta D Kraneveld; Mirjam Kool; Anneke H van Houwelingen; Paul Roholl; Alan Solomon; Dirkje S Postma; Frans P Nijkamp; Frank A Redegeld
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-14       Impact factor: 11.205

2.  Ablation of tumor progression locus 2 promotes a type 2 Th cell response in Ovalbumin-immunized mice.

Authors:  Wendy T Watford; Chun-Chi Wang; Christos Tsatsanis; Lisa A Mielke; Aristides G Eliopoulos; Constantine Daskalakis; Nicolas Charles; Sandra Odom; Juan Rivera; John O'Shea; Philip N Tsichlis
Journal:  J Immunol       Date:  2009-12-02       Impact factor: 5.422

Review 3.  Non-eosinophilic asthma: importance and possible mechanisms.

Authors:  J Douwes; P Gibson; J Pekkanen; N Pearce
Journal:  Thorax       Date:  2002-07       Impact factor: 9.139

Review 4.  Therapeutic applications of monoclonal antibodies.

Authors:  Mitchell Berger; Vidya Shankar; Abbas Vafai
Journal:  Am J Med Sci       Date:  2002-07       Impact factor: 2.378
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.